XML 41 R34.htm IDEA: XBRL DOCUMENT v3.20.4

SEGMENT REPORTING (Tables)

12 Months Ended

Sep. 30, 2020

SEGMENT REPORTING

Schedule of segment information

The following table presents segment information for years ended September 30, 2020, 2019 and 2018, respectively:

		For the year ended September 30, 2020
		Oxytetracycline
		& Licorice						Heparin
		products and						products and
		TCMD			Fertilizer			Sausage casing			Total
Revenue		$	32,602,384		$	701,701		$	16,729,115		$	50,033,200
Cost of revenue			25,004,712			304,670			17,184,665			42,494,047
Gross profit		$	7,597,672		$	397,031		$	(455,550)		$	7,539,153
Depreciation and amortization		$	886,322		$	38,792		$	180,473		$	1,105,587
Capital expenditures		$	377,953		$	33,914		$	37,898		$	449,765

		For the year ended September 30, 2019
		Oxytetracycline
		& Licorice						Heparin
		products and						products and
		TCMD			Fertilizer			Sausage casing			Total
Revenue		$	30,149,950		$	549,231		$	15,397,503		$	46,096,684
Cost of revenue			22,324,422			186,504			13,905,846			36,416,772
Gross profit		$	7,825,528		$	362,727		$	1,491,657		$	9,679,912
Depreciation and amortization		$	985,212		$	38,525		$	164,436		$	1,188,173
Capital expenditures		$	331,917		$	5,598		$	278,873		$	616,388

		For the year ended September 30, 2018
		Oxytetracycline
		& Licorice						Heparin
		products and						products and
		TCMD			Fertilizer			Sausage casing			Total
Revenue		$	33,429,330		$	713,896		$	16,225,787		$	50,369,013
Cost of revenue			26,159,584			235,319			15,841,870			42,236,773
Gross profit		$	7,269,746		$	478,577		$	383,917		$	8,132,240
Depreciation and amortization		$	1,070,824		$	38,057		$	145,177		$	1,254,098
Capital expenditures		$	628,604		$	486,501		$	16,225,787		$	1,117,175

		September 30,			September 30,
		2020			2019
Total Assets
Oxytetracycline & Licorice products and TCMD		$	34,370,665		$	23,251,452
Fertilizer		$	2,438,442		$	2,149,680
Heparin products and Sausage casing		$	11,334,031		$	9,867,112
Total		$	48,143,138		$	35,268,244

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 350
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration